Opioid abuse comes in many forms; and it's not just the stereotypical junkie that's doctor shopping and trying to refill their Norco 2 weeks early "because the cops stole them." Opioid abuse can also show up in more insidious ways.....
Read MoreDrug
Adalimumab-atto [Amjevita]
Indication
Amjevita is a biosimilar to adalimumab [Humira], so it has the same indications. It's used in inflammatory conditions mediated by the immune system
Read MoreWell, we're coming full circle here. Our epic series on HIV is nearing its coda. We've only got one "class" of HIV meds left to talk about.
The Entry Inhibitors.
Read MoreBefore we get too far, let’s clarify what drugs fall in the aminoglycoside class. That way we’re all on the same page. When we talk about aminoglycosides, we’re referring to gentamicin, tobramycin, and amikacin.
Read MoreIntegrase Inhibitors (also known as IN Strand Transfer Inhibitors...or commonly abbreviated as INSTIs) first appeared on the market in 2007. This may come as a surprise to you, but their job is to inhibit the HIV enzyme Integrase.
What does Integrase do?
Read MorePIs. Ahhh the ever-so-important private investigators.
Err...I mean protease inhibitors.
You may recall that we've already discussed protease inhibitors in our post on Hepatitis C.
Read MoreHowdy all. This is just a quick note to let you know that I wrote a short piece for Pharmacy Times.
You can check it out here:
Read MoreI have a confession to make...
I didn't "get" acid-base disorders until well after pharmacy school. They were something I was willing to skate through. To take an "L" on the exam if I had to.
Read MoreNon-Nucleoside Reverse Transcriptase Inhibitors, or NNRTIs (pronounced like NRTIs, but with a stutter), are the next class of HIV drugs we will be covering.
What makes a NON-nucleoside as opposed to a regular old fashioned nucleoside reverse transcriptase inhibitor?
Read MoreOncology pharmacy is hard.
Like, really hard.
You get a 3 - 5 week module during school. Maybe you have an APPE rotation. But there's just too much. Too many types of cancers. Too much history that explains how we got to where we are.
Read More